- |||||||||| Humira (adalimumab) / AbbVie
Enrollment closed: Chronic Plaque Psoriasis (Ps) Registry (clinicaltrials.gov) - Dec 10, 2012 P=N/A, N=6000, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Humira (adalimumab) / Eisai, AbbVie
Trial initiation date: Long Term Open Label Continuation Study (clinicaltrials.gov) - Aug 23, 2012 P3, N=846, Completed, Recruiting --> Active, not recruiting Initiation date: Feb 2000 --> Jul 2000
- |||||||||| Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J, Enbrel (etanercept) / Pfizer, Amgen, Humira (adalimumab) / Eisai, AbbVie
Clinical: TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis (clinicaltrials.gov) - Aug 2, 2012 P=N/A, N=60, Recruiting,
|